Pridopidine is back!

Dr. Michael Hayden and his company Prilena, just announced that the Pridopidine clinical trial will be restarted!   They have now secured the needed funds to do a phase 3 clinical trial in HD with the Pridopidine.  The study will be done in North America and Europe with several hundred participants! Pridopidine has a long history in HD and many of you will know it as ACR16 or Huntexil.